PDS BIOTECHNOLOGY CORPORATION - COMMON STOCK
3.2010
01-11月-24 14:59:58
15 分の遅延
株式
+0.0110
+0.34%
本日の幅
3.1500 - 3.3500
ISIN
N/A
ソース
NASDAQ
-
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
27 3 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
20 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
13 3 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
22 1 2024 15:45:19 提供 Nasdaq GlobeNewswire
-
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
16 1 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04 12 2023 15:50:00 提供 Nasdaq GlobeNewswire
-
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
28 11 2023 06:30:00 提供 Nasdaq GlobeNewswire
-
PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
14 11 2023 06:30:55 提供 Nasdaq GlobeNewswire
-
PDS Biotechnology Announces Conference Call and Webcast for Third Quarter 2023 Financial Results
07 11 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
23 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
02 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
PDS Biotech to Present at the LD Micro Main Event XVI
26 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
20 9 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
20 9 2023 07:00:18 提供 Nasdaq GlobeNewswire
-
PDS Biotech to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
06 9 2023 15:05:00 提供 Nasdaq GlobeNewswire